Regulation of Cytokines/Chemokines Release and Anti-Tumor Effect of Expanded Natural Killer (NK) Cells by a Novel Fusion of N-820 (2b8t2m), an Il-15 Superagonist with 4 Single-Chain Anti-Cd20 Antibody Domains, Against Rituximab Resistant Burkitt Lymphoma (Bl)

Authors

Yaya Chu, New York Medical CollegeFollow
Olivia Negron
Gaurav Nayyar
Jeremy Rosenblum, New York Medical CollegeFollow
Emily Jeng
P R. Rhode
D A. LeeFollow
H C. Wong
J H. Lee, New York Medical College
Mitchell S. Cairo, New York Medical CollegeFollow

Author Type(s)

Faculty, Student

Document Type

Abstract

Publication Date

6-2019

Journal Title

Pediatric Blood & Cancer

Department

Pediatrics

Second Department

Health Behavior and Community Health

Recommended Citation

Chu, Y., Negron, O., Nayyar, G., Rosenblum, J., Jeng, E., Rhode, P. R., Lee, D. A., Wong, H. C., Lee, J. H., & Cairo, M. S. (2019). Regulation of Cytokines/Chemokines Release and Anti-Tumor Effect of Expanded Natural Killer (NK) Cells by a Novel Fusion of N-820 (2b8t2m), an Il-15 Superagonist with 4 Single-Chain Anti-Cd20 Antibody Domains, Against Rituximab Resistant Burkitt Lymphoma (Bl). Pediatric Blood & Cancer, 66 (Suppl. 2), 1027. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/274